Cutting-edge medical morphine-methamphetamine 2-in-1 rapid test reagent
Taiwan·Risk Class 2·Formosa Biomedical Technology Co., Ltd. Yilan Factory·Registered Nov 16, 2018 – Aug 24, 2022Cancelled- Analysis ID
- dd2ce72900b28f25ccdcadfb2d3eb80b
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
- Intended Use
- This product uses competitive immunochromatography to qualitatively detect methamphetamine or morphine in human urine. This product can be used by both individuals and professionals.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3640 嗎啡試驗系統
- Import Information
- Domestic;; Contract manufacturing
- Registration Date
- Nov 16, 2018
- Expiry Date
- Aug 24, 2022
- Cancellation Date
- Apr 12, 2024
- Status
- Logged out
- Reason
- 許可證已逾有效期
Access comprehensive regulatory information for Cutting-edge medical morphine-methamphetamine 2-in-1 rapid test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number dd2ce72900b28f25ccdcadfb2d3eb80b and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.